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Recent changes in the tobacco and nicotine market make it more important than ever to 
have valid and reliable measures of tobacco and nicotine use that capture population 
exposure. New smoking prevalence estimates frequently make national headlines, and are 
regularly used to: 1) understand the consequences of tobacco and nicotine use on public 
health and 2) compare estimates across jurisdictions to understand how different tobacco 
control policies may be affecting smoking prevalence. Here, we call attention to some 
problems with existing smoking surveillance measures and methods, using the example of 
adult cigarette smoking prevalence in the United States (US). 
 
Several factors can lead smoking prevalence estimates to be misinterpreted or distorted. 
First, non-cigarette combustible tobacco products such as small filtered cigars (that are often 
used like cigarettes), cigars, cigarillos, pipes, and bidis are not always included in 
prevalence estimates. Many of these products have similar consequences for public health 
as cigarettes and should be included in smoking prevalence estimates. Moreover, they are 
often not subject to the same tobacco control measures as cigarettes (e.g., taxes, minimum 
pack size) and thus may be cheaper or more accessible than cigarettes. Second, the survey 
design underlying these estimates, including survey mode and sampling method, can affect 
who is included in samples, potentially under- or over-sampling certain populations and 
yielding estimates that are higher or lower than the true values. Third, national prevalence 
figures vary by the age used to define adulthood, with some surveys using 18+ and others 
using younger thresholds. Finally, the definition of a “smoker” in headline rates can vary as 
well, such as past 30 day use, daily smoking, or every day/some day smoking. Some 
definitions include additional conditions such as a 100 lifetime cigarette threshold, which 
combined with different thresholds for other tobacco and nicotine products in some cases 
(e.g., 50 times for cigar type products and 1 time for electronic cigarettes), further 
complicates interpretation(1). The public health impact of smoking and the possible effects 
of policies or lack thereof may be misinterpreted if these factors are not considered. 
 
The US is one example of a country where adult cigarette smoking prevalence estimates are 
affected by some of these factors. Several surveys are used to measure tobacco use among 
US adults. We focus on the US National Health Interview Survey (NHIS) here because the 
US Centers for Disease Control (CDC) employs the NHIS to highlight smoking prevalence 
estimates in factsheets(2). A recent New York Times article also highlighted that US adult 
cigarette smoking dropped to 15% in 2015 according to the NHIS(3). 
 
This NHIS headline figure of 15.1%, which includes every day or some day cigarette 
smoking and a 100 cigarette threshold, likely underestimates population exposure to 
combustible tobacco smoking in the US(1).The NHIS headline estimate excludes people 
using non-cigarette combustible tobacco products. Using annualized data from NHIS 2012-
2014, we find that the prevalence of non-cigarette combustible tobacco use, including 
products such as cigars, cigarillos, and bidis among adults 18+ is 1.9%, with 0.8% using 
every day, 1.1% using some days, and an additional 4.4% rarely using (rare use is an 
additional response option included for non-cigarette combustible products)(4). If we 
consider young adults (18-24), we see the prevalence estimate is even higher at 2.7%, with 
0.6% using every day, 2.1% some days, and an additional 8.8% rarely using(4). While it is 
possible that some proportion of non-cigarette combustible tobacco use is concurrent with 
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cigarette smoking, it is likely that overall combustible tobacco use prevalence for adults 18+ 
in the US is higher than 15.1%, and somewhere in line or just below the 2013-2014 National 
Adult Tobacco Survey (NATS) estimate that 18.4% of US adults aged 18+ were current 
users of any combustible tobacco product (defined by NATS as every day or some day use, 
with different thresholds of lifetime use by combustible tobacco product)(5). 
 
Additionally, similar to other countries, US NHIS data highlight that cigarette smoking 
prevalence is higher in population subgroups, including sexual minorities (20.6%), those of 
low socioeconomic status (i.e., below the poverty level, 26.1%), and those with serious 
psychological distress (40.6%)(1). It is well documented that it has been increasingly difficult 
to recruit nationally representative survey samples in recent decades. Thus, it is possible 
that the US NHIS cigarette smoking prevalence estimate is low if members of groups who 
are difficult to engage in survey samples are underrepresented.  
 
Comparing across another dataset, the NHIS cigarette smoking prevalence estimate 
(15.1%) is also lower than seen in cigarette (21.0%) smoking rates among persons aged 
18+ in the 2015 National Survey on Drug Use and Health (NSDUH)(6). NSDUH’s primary 
measure of current cigarette use asks about past-month use rather than every day or some 
days as used in NHIS, and unlike the NHIS does not use the 100 cigarette threshold. The 
NHIS estimate is low even when compared to NSDUH’s prevalence estimate in persons 
aged 12 and older (19.4%). However, asking about past-month tobacco and nicotine product 
use as done in the NSDUH has been previously documented to overestimate regular 
use(7,8). Nevertheless, this difference in cigarette smoking prevalence illustrates how 
different methods can affect national prevalence estimates, making them difficult to compare 
not only across jurisdictions but even within countries. 
 
The public health impact of combustible tobacco use in the US is arguably distorted by 
headline cigarette smoking prevalence estimates because they often exclude non-cigarette 
combustible tobacco use, use imprecise definitions of current smoking, and may be subject 
to other factors such as underrepresentation of difficult to engage groups. Cross-survey and 
cross-national comparisons of smoking prevalence estimates, including non-cigarette 
combustible products, are necessary to provide meaningful information to researchers, 
advocates, and policymakers. Rapid changes in the tobacco and nicotine marketplace and 
policy environment further highlight the need for surveillance measures to be harmonised, 
and for reporting and interpretation to be carefully conducted. 
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